MENU
+Compare
SPRB
Stock ticker: NASDAQ
AS OF
Dec 24 closing price
Price
$84.00
Change
+$0.26 (+0.31%)
Capitalization
89.91M

SPRB Spruce Biosciences Inc Forecast, Technical & Fundamental Analysis

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs... Show more

SPRB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for SPRB with price predictions
Dec 23, 2025

SPRB's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for SPRB turned positive on December 23, 2025. Looking at past instances where SPRB's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 66 cases where SPRB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SPRB advanced for three days, in of 241 cases, the price rose further within the following month. The odds of a continued upward trend are .

SPRB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 23, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SPRB as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

SPRB moved below its 50-day moving average on November 28, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SPRB crossed bearishly below the 50-day moving average on December 02, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SPRB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SPRB entered a downward trend on December 23, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SPRB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (16.694) is normal, around the industry mean (26.864). P/E Ratio (0.000) is within average values for comparable stocks, (51.341). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.882). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (69.930) is also within normal values, averaging (312.120).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SPRB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
SPRB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
611 Gateway Boulevard
Phone
+1 415 655-4168
Employees
29
Web
https://www.sprucebiosciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SGAMY3.950.08
+2.06%
Sega Sammy Holdings, Inc.
BKZHY25.87N/A
N/A
Santander Bk Polska SA
PYNKF0.30N/A
-0.92%
Perimeter Medical Imaging AI, Inc.
RMLFF0.70-0.01
-1.64%
Rusoro Mining Ltd.
PLSH0.05-0.02
-31.16%
Panacea Life Sciences Holdings, Inc.

SPRB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRB has been loosely correlated with NEVPF. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRB jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRB
1D Price
Change %
SPRB100%
+1.11%
NEVPF - SPRB
61%
Loosely correlated
N/A
IMRX - SPRB
52%
Loosely correlated
+8.12%
MLEC - SPRB
51%
Loosely correlated
-28.89%
IMCR - SPRB
37%
Loosely correlated
+0.58%
VYNE - SPRB
35%
Loosely correlated
-1.27%
More